{"disease":{"id":"elevated-intraocular-pressure","name":"elevated intraocular pressure"},"drugs":{"marketed":[{"drug_id":"timolol-maleate","indication_name":"Reduction of Elevated Intraocular Pressure","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"TIMOLOL MALEATE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":9,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04962009","title":"Safety and Intraocular Lowering Effect of Delivery of Travoprost Evolute® in Subjects With Elevated Intraocular Pressure","phase":"","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"Mati Therapeutics Inc.","has_results":true}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}